IndiaTickerParmax Pharma Ltd - 540359 - Updates on Open OfferBSE · exchange filing · pdf
Source filing Company dossier
Parmax Pharma
BSE:PARMAX · ISIN INE240T01014
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Parmax Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Parmax Pharma Ltd - 540359 - Updates on Open OfferBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Letter of OfferBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The CompanyBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Draft Letter of OfferBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Detailed Public StatementBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - EGM Scheduled To Be Held On July 02, 2026BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Open OfferBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Results-Delay in Financial ResultsBSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Fund RaisingBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended Marc 31, 2026BSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Considering Audited Financial Results Of Quarter And Financial Year Ended On March 31, 2026BSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Extra Ordinary General Meeting Scheduled To Be Held On May 27, 2026BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Appointment of Company Secretary and Compliance OfficerBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of Board MeetingBSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Unaudited Financial Results For Quarter And Nine Months Ended 31.12.2025BSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Consider And Approve Unaudited Financial Results For Quarter And Nine Months Ended On December 31, 2025BSE · financial results · pdf
Source filing Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Parmax Pharma Ltd - 540359 - Results-Delay in Financial ResultsBSE · financial results · pdf
Source filing